The successful applicant will join an active program to expand our understanding of this therapeutic strategy. He/she will work collaboratively with other pathologists, research scientists, and members of clinical drug development teams to identify, characterize and develop novel anti-angiogenic therapies. He/she will also conduct an independent, internally funded angiogenesis research program supporting the overall goals of the group.